Revenue: The sum of all revenue fields included for a company's operating activities.
Madrigal Pharmaceuticals, Inc. (MDGL) had Revenue of $321.08M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$321.08M |
$-58.58M |
|
$24.45M |
|
$296.63M |
|
$380.69M |
|
$-59.61M |
|
$1.03M |
|
$-58.58M |
|
$-58.58M |
|
$-58.58M |
|
$-58.58M |
|
$-58.58M |
|
$-58.58M |
|
$-59.61M |
|
$-57.20M |
|
22.43M |
|
22.43M |
|
$-2.55 |
|
$-2.55 |
|
| Balance Sheet Financials | |
$1.25B |
|
$1.50M |
|
$13.82M |
|
$1.26B |
|
$310.29M |
|
$339.88M |
|
$346.61M |
|
$656.90M |
|
$602.69M |
|
$595.31M |
|
$602.69M |
|
22.84M |
|
| Cash Flow Statement Financials | |
$-189.55M |
|
$32.32M |
|
$255.98M |
|
$105.02M |
|
$203.78M |
|
$98.76M |
|
$98.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.01 |
|
-- |
|
-- |
|
0.36 |
|
0.56 |
|
92.39% |
|
-18.57% |
|
-18.57% |
|
-- |
|
-18.24% |
|
-18.24% |
|
$-190.02M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.33 |
|
2.39 |
|
37.69 |
|
-9.72% |
|
-9.84% |
|
-4.65% |
|
-6.21% |
|
$26.39 |
|
$-8.47 |
|
$-8.45 |
|